Table 5.
MCI | AD | DLB/PDD | FTD | VaD | |
---|---|---|---|---|---|
Number of patients | 22 | 37 | 19 | 3 | 5 |
Age | 69.8 (5.4), 61–78 | 68.9 (8.7), 50–84 | 68.1 (7.7), 56–81 | 71 (11.4), 63–84 | 73.0 (10.8), 58–86 |
MMSE | 26.8 (1.9), 22–29 | *24.4 (3.4), 16–29 | 25.1 (3.5), 14–30 | 26.3 (3.8), 22–29 | 25.0 (3.0), 22–30 |
Sex (M:F) | 9:13 | 16:21 | 9:10 | 2:1 | 3:2 |
Follow-Up Duration | 25.1 (19.3), 6–59 | 34.4 (22.6), 2–83 | *37.4 (16.6), 8–66 | 19.7 (11.3), 7–29 | 36.4 (15.9), 11–52 |
*p < 0.05, student t-test between MCI and other disease group. Sex ratio is compared by chi-square test. AD patients and other disease groups are not significantly different.